IL17A and prostate carcinoma: Among the pathways, the PI3K-Akt signaling pathway, prostate cancer, bladder cancer, pancreatic cancer, IL-17 signaling pathway, non-small cell lung cancer, TNF signaling pathway, and small cell lung cancer showed more connections with the potential targets.